[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349739-105":59,"doc-detail-349739-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeted-therapy-and-biomarker-guided-applications-of-ecofriendly-silver-nanoparticles-in-precision-oncology","Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology","","Eco-friendly silver nanoparticles (eco-AgNPs) combine green nanotechnology with precision oncology to support cancer treatment. This minireview evaluates eco-friendly AgNPs synthesized using plant extracts and microorganisms, highlighting improved biocompatibility and selective cytotoxicity toward malignant cells. Multiple anticancer mechanisms are reviewed, including reactive oxygen species generation, apoptosis induction, and cell cycle disruption, alongside biomarker-guided targeting via antibodies and aptamers. Theranostic platforms for imaging and therapy are discussed, as well as barriers to clinical translation such as toxicity, protocol standardization, and regulatory approval.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeted-therapy-and-biomarker-guided-applications-of-ecofriendly-silver-nanoparticles-in-precision-oncology/349739/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeted-therapy-and-biomarker-guided-applications-of-ecofriendly-silver-nanoparticles-in-precision-oncology/349739.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How do eco-friendly silver nanoparticles target cancer cells in precision oncology?","Question",{"text":113,"@type":114},"They target cancer through mechanisms such as reactive oxygen species generation, apoptosis induction, and cell cycle disruption. Selectivity is further supported by surface functionalization with targeting moieties like antibodies and aptamers that recognize tumor receptors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What enables biomarker-guided delivery using eco-AgNPs?",{"text":118,"@type":114},"Biomarker-guided design supports tumor-specific delivery by exploiting unique metabolic signatures and cellular markers characteristic of different cancer types.",{"name":120,"@type":111,"acceptedAnswer":121},"What are the main obstacles to clinical translation of eco-AgNPs?",{"text":122,"@type":114},"Clinical implementation is challenged by potential long-term toxicity, batch-to-batch variability requiring protocol standardization, and regulatory approval pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349739,1790477284,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 13 January 2026 DOI 10.3389/jpps.2025.15403  \nOPEN ACCESS  \nEDITED BY  \nAna C. Henriques,  \nCatholic University of Portugal, Portugal  \n*CORRESPONDENCE  \nHaider Hamzah,  \n [haider.hamzah@univsul.edu.iq](haider.hamzah@univsul.edu.iq)  \nRECEIVED 08 August 2025  \nREVISED 16 December 2025  \nACCEPTED 31 December 2025  \nPUBLISHED 13 January 2026  \nCITATION  \nHamzah H (2026) Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology.  \nJ. Pharm. Pharm. Sci. 28:15403 .  \ndoi: 10.3389/jpps.2025.15403  \nCOPYRIGHT  \n© 2026 Hamzah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTargeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology  \nHaider Hamzah 􀀁 *  \nDepartment of Biology, University of Sulaimani, Sulaymaniyah, Kurdistan, Iraq  \nEco-friendly silver nanoparticles (eco-AgNPs) represent a promising convergence of green nanotechnology and precision medicine for cancer treatment. This minireview examines the therapeutic potential of silver nanoparticles (AgNPs) synthesized through eco-friendly methods using plant extracts and microorganisms. These eco-friendly AgNPs demonstrate enhanced biocompatibility and selective cytotoxicity against malignant cells. These nanoparticles target cancer through multiple mechanisms including reactive oxygen species generation, apoptosis induction, and cell cycle disruption. Selectivity is achieved through surface functionalization with targeting moieties such as antibodies and aptamers that recognize overexpressed tumor receptors. The integration of biomarker-guided design enables tumor-specific delivery by exploiting unique metabolic signatures and cellular markers characteristic of different cancer types. Furthermore, AgNPbased theranostic platforms offer simultaneous diagnostic imaging and therapeutic intervention, providing real-time assessment of treatment response and enabling personalized dosing strategies. However, clinical translation faces significant challenges including potential long-term toxicity, standardization of synthesis protocols, and regulatory approval pathways. Successful clinical implementation will require interdisciplinary collaboration to optimize nanoparticle design, establish safety profiles, and develop combination therapies that maximize therapeutic benefits while minimizing side effects. Eco-AgNPs thus offer a transformative approach to cancer treatment that combines environmental sustainability with precision targeting capabilities.  \nKEYWORDS  \ncancer therapy, precision oncology, silver nanoparticles, targeted drug delivery, theranostics  \nJournal of Pharmacy & Pharmaceutical Sciences 01  \nPublished by Frontiers Canadian Society for Pharmaceutical Sciences  \nIntroduction  \nPrecision oncology has transformed cancer treatment from generalized approaches to personalized strategies guided by tumor genetics and molecular biomarkers [ 1]. This paradigm maximizes therapeutic efficacy while minimizing adverse effects through targeted interventions. Nanotechnology has further advanced precision oncology by enabling novel drug delivery systems with enhanced bioavailability and tumor-specific targeting [2]. Among nanomaterials, eco-friendly silver nanoparticles (eco-AgNPs) are particularly promising, owing to their unique physicochemical properties and inherent antiproliferative activity [3–6]. While chemically synthesized AgNPs offer precise control over size and morphology, their reliance on toxic reducing agents (e.g., sodium borohydride) raises concerns abou","cbCail8Orgfzyqy4","https://ap.wps.com/l/cbCail8Orgfzyqy4","pdf",2871249,11,"English","# Introduction\n## Precision oncology and nanotechnology\n## Eco-friendly silver nanoparticles and green synthesis\n# Mechanisms of action of eco-AgNPs in cancer therapy\n## Ag+ release and mitochondrial disruption\n## DNA/protein interactions and ROS generation\n## Biomarker-specific functionalization and targeting\n# Biomarker-guided applications and theranostic platforms\n# Challenges in clinical translation\n## Toxicity, standardization, and regulatory pathways","[{\"question\":\"How do eco-friendly silver nanoparticles target cancer cells in precision oncology?\",\"answer\":\"They target cancer through mechanisms such as reactive oxygen species generation, apoptosis induction, and cell cycle disruption. Selectivity is further supported by surface functionalization with targeting moieties like antibodies and aptamers that recognize tumor receptors.\"},{\"question\":\"What enables biomarker-guided delivery using eco-AgNPs?\",\"answer\":\"Biomarker-guided design supports tumor-specific delivery by exploiting unique metabolic signatures and cellular markers characteristic of different cancer types.\"},{\"question\":\"What are the main obstacles to clinical translation of eco-AgNPs?\",\"answer\":\"Clinical implementation is challenged by potential long-term toxicity, batch-to-batch variability requiring protocol standardization, and regulatory approval pathways.\"}]","Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology | PDF",1790085337,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10b966a5d0fac5bea6c7adefc1e1a97a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0c0da54c83225db48f8f04fe0ae335f.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdf182e4f4094e0bdc62031ba6e1be93.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea6036ebdf0946282e43037ed7a1e17f.webp",980,1385]